Customary 发表于 2025-3-26 23:48:59
http://reply.papertrans.cn/88/8763/876294/876294_31.pngCON 发表于 2025-3-27 01:24:23
http://reply.papertrans.cn/88/8763/876294/876294_32.png针叶树 发表于 2025-3-27 07:50:09
Prevalence of SAMS in Observational and Clinical Trials,ablishing the rate of SAMS in the statin-using population has been problematic. Both observational and clinical trials have produced widely disparate estimates of SAMS prevalence, due in part to methodological variance in patient selection, definition of SAMS, study design, and data collection technGRAVE 发表于 2025-3-27 12:41:29
http://reply.papertrans.cn/88/8763/876294/876294_34.png运动性 发表于 2025-3-27 15:37:45
Large Clinical Trials of Statin-Associated Muscle Symptoms,h as low-dose statins, or other lipid-modifying therapies (LMT) such as red yeast rice, ezetimibe, or berberine, have not proven to be an adequate alternative. Additionally, comprehensive clinical trials examining alternative therapy for SAMS are lacking. The discovery and understanding of proproteicortex 发表于 2025-3-27 20:55:02
http://reply.papertrans.cn/88/8763/876294/876294_36.pngPalpitation 发表于 2025-3-27 22:55:01
The Effect of Statins on Exercise Performance and Exercise Training, statins on: (1) skeletal muscle strength, (2) aerobic exercise performance, (3) skeletal muscle and cardiac biomarkers during exercise, (4) training for athletic competition, and (5) physical activity adherence. The majority of evidence does not demonstrate a deleterious effect of statin therapy onEXCEL 发表于 2025-3-28 02:18:53
Genetic Risk Factors for Statin-Associated Muscle Symptoms (SAMS), studies have identified various loci that seem to be associated with an increased risk of SAMS, but the statin-specific and phenotype-dependent association of simvastatin with .∗5 remains the most clinically relevant relationship. Lack of confirmatory data in replication cohorts and exclusion of inFeature 发表于 2025-3-28 07:34:25
http://reply.papertrans.cn/88/8763/876294/876294_39.png吵闹 发表于 2025-3-28 10:25:26
The Role of Muscle Protein and Energy Metabolism in Statin-Associated Muscle Symptoms,es in Akt/FOXO signalling. Forcibly increasing muscle carbohydrate flux under these conditions by pharmacological means blocks statin myopathy. Human volunteer research has delivered less definitive mechanistic insight of the aetiology of statin-related metabolic dysregulation, with little evidence